Imunon (IMNN) Chief Medical Officer Vincent Buys $38K of Stock
Chief Medical Officer Douglas Vincent Faller purchased 21,896 shares of IMNN.
Reviewed by automated data checks against the source filing. How we make and check alerts
Faller Douglas Vincent, Chief Medical Officer at Imunon, Inc. ($IMNN), bought 21,896 shares at an average price of $1.72, worth about $37,661.12, on June 25, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $IMNN is up 11.1% after 1 week, down 11.1% after 1 month and down 40.7% to date (from the $1.72 close on Jun 25, 2026).
IMNN
Imunon, Inc.
Key Points
- Douglas Vincent Faller, Chief Medical Officer of IMNN, bought 21,896 shares at $1.72, totaling $37,661.12 on June 25, 2026.
- Shares of IMNN traded near $1.80 on Tuesday, reflecting recent insider buying activity.
- Analysts from Maxim Group and others maintain a buy rating, with price targets up to $29.00.
Get $IMNN trade alerts by text
We text you when insiders, Congress or big funds trade $IMNN. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Imunon, Inc. alert may contain errors. Disclosures
Douglas Vincent Faller, the Chief Medical Officer at IMNN, recently bought 21,896 shares of the company at an average price of $1.72 each. This purchase, made on June 25, 2026, was valued at $37,661.12. The transaction wasn't part of a pre-planned trading program.
Insider Buying and Selling at Imunon, Inc.
In addition to Faller's purchase, other executives at IMNN were active in acquiring shares. Michael Tardugno, Executive Chairman of the Board, bought 42,519 shares at $1.72 on June 25, 2026, and additional shares earlier in the month at $1.82 and $2.06. Stacy Lindborg, President and CEO, purchased 67,150 shares at $1.72 and 1,803 shares at $1.82 in June.
Other Institutional Activity in IMNN
Armistice Capital, LLC increased its holdings in IMNN by 81,444 shares, ending with 348,330 shares valued at approximately $1,024,090, marking a 30.5% increase. Vanguard Capital Management LLC opened a new position with 48,056 shares worth about $141,285. Geode Capital Management, LLC also boosted its position by 11,989 shares to a total of 33,211 shares valued at $97,644.
Imunon, Inc. Stock Up 32.4%
Shares of IMNN traded near $1.80 on Tuesday. The company has been attracting attention with recent insider buying activities. While specific financial metrics aren't available, the stock's trading price reflects recent market movements and investor interest.
Analysts Set New Price Targets
On April 17, 2026, Maxim Group initiated coverage on IMNN with a buy rating and set a price target of $10.00. Other analysts, including D. Boral Capital and HC Wainwright & Co., have maintained a buy rating, with targets reaching as high as $29.00.
Bottom Line
Douglas Vincent Faller's recent purchase of IMNN shares highlights insider confidence in the company's prospects. Such transactions are often watched closely by investors as they can provide insights into the company's future. Analysts continue to support the stock with buy ratings and high price targets, suggesting optimism about its potential.
Related Filing Alerts
Source: Faller Douglas Vincent's Form 4 filing on $IMNN (Jun 25, 2026). Find the original filing: IMNN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts